Biodistribution in Sprague-Dawley rat cerebellum assessed as increase in uptake at 0.07 to 0.11 nmol, iv pre-treated with 3 mg/kg of SB269970 measured up to 90 mins by HPLC analysis relative to control
Biodistribution in Sprague-Dawley rat thalamus assessed as increase in uptake at 0.07 to 0.11 nmol, iv pre-treated with 3 mg/kg of SB269970 measured up to 90 mins by HPLC analysis relative to control
Biodistribution in Sprague-Dawley rat hippocampus assessed as increase in uptake at 0.07 to 0.11 nmol, iv pre-treated with 3 mg/kg of SB269970 measured up to 90 mins by HPLC analysis relative to control
Biodistribution in Sprague-Dawley rat frontal cortex assessed as increase in uptake at 0.07 to 0.11 nmol, iv pre-treated with 3 mg/kg of SB269970 measured up to 90 mins by HPLC analysis relative to control
Binding affinity to 5-HT7 in Sprague-Dawley rat brain assessed as reduction in total radioactivity at 1 nM after 30 mins by autoradiography in presence of SB269970
Binding affinity to 5-HT7 in Sprague-Dawley rat brain assessed as reduction in total radioactivity at 1 nM after 30 mins by autoradiography in presence of unlabelled compound